Invenomic Capital Management’s Caleres CAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.2M Sell
902,633
-201,380
-18% -$2.61M 0.67% 53
2026
Q1
$11.6M Buy
1,104,013
+72,139
+7% +$860K 0.53% 61
2025
Q4
$12.6M Buy
1,031,874
+160,274
+18% +$1.97M 0.58% 59
2025
Q3
$11.4M Buy
871,600
+143,175
+20% +$2.07M 0.55% 66
2025
Q2
$8.9M Buy
728,425
+55,414
+8% +$831K 0.51% 69
2025
Q1
$11.6M Buy
+673,011
New +$12.1M 0.59% 63
2022
Q2
Sell
-162,993
Closed -$2.5M 153
2022
Q1
$2.5M Buy
162,993
+109,609
+205% +$2.38M 0.27% 88
2021
Q4
$1.21M Buy
+53,384
New +$1.27M 0.26% 101
2021
Q2
Sell
-47,807
Closed -$1.04M 127
2021
Q1
$1.04M Sell
47,807
-70,277
-60% -$1.2M 0.23% 80
2020
Q4
$1.85M Sell
118,084
-58,272
-33% -$652K 0.47% 43
2020
Q3
$1.69M Sell
176,356
-62,273
-26% -$500K 0.93% 39
2020
Q2
$1.99M Buy
238,629
+67,315
+39% +$471K 1.47% 18
2020
Q1
$891K Buy
171,314
+56,609
+49% +$813K 0.73% 51
2019
Q4
$2.72M Buy
+114,705
New +$2.59M 1.09% 37

Other funds holding CAL

Invenomic Capital Management's CAL Position: Q2 2026 in Review

Invenomic Capital Management reduced its Caleres (CAL) stake by 18% in Q2 2026, selling an estimated $2.61M and leaving 902,633 shares worth $11.2M. The position accounts for 0.67% of the portfolio, ranked #53.

Invenomic Capital Management first reported a position in CAL in Q4 2019 and has held it in 14 quarters since. The position peaked at $12.6M in Q4 2025. 170 funds tracked by Wall St. Rank hold CAL as of Q2 2026.

  • Invenomic Capital Management held 902,633 shares of Caleres worth $11.2M as of Q2 2026.
  • Invenomic Capital Management sold 201,380 Caleres shares in Q2 2026, an estimated $2.61M.
  • Caleres made up 0.67% of Invenomic Capital Management's portfolio in Q2 2026, its #53 holding.
  • Invenomic Capital Management first reported a position in Caleres in Q4 2019 and has held it in 14 quarters since.
  • Invenomic Capital Management's Caleres position peaked at $12.6M in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Caleres as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.